Style | Citing Format |
---|---|
MLA | Gholibeigian Z, et al.. "Decreased Serum Levels of Interleukin-17, Interleukin-23, Tgf-Β in Pemphigus Vulgaris Patients, and Their Association With Disease Phase." Dermatologic Therapy, vol. 33, no. 6, 2020, pp. -. |
APA | Gholibeigian Z, Izad M, Daneshpazhooh M, Mortazavi H, Salehi Z, Behruzifar S, Akhdar M, Tavakolpour S, Azizpour A (2020). Decreased Serum Levels of Interleukin-17, Interleukin-23, Tgf-Β in Pemphigus Vulgaris Patients, and Their Association With Disease Phase. Dermatologic Therapy, 33(6), -. |
Chicago | Gholibeigian Z, Izad M, Daneshpazhooh M, Mortazavi H, Salehi Z, Behruzifar S, Akhdar M, Tavakolpour S, Azizpour A. "Decreased Serum Levels of Interleukin-17, Interleukin-23, Tgf-Β in Pemphigus Vulgaris Patients, and Their Association With Disease Phase." Dermatologic Therapy 33, no. 6 (2020): -. |
Harvard | Gholibeigian Z et al. (2020) 'Decreased Serum Levels of Interleukin-17, Interleukin-23, Tgf-Β in Pemphigus Vulgaris Patients, and Their Association With Disease Phase', Dermatologic Therapy, 33(6), pp. -. |
Vancouver | Gholibeigian Z, Izad M, Daneshpazhooh M, Mortazavi H, Salehi Z, Behruzifar S, et al.. Decreased Serum Levels of Interleukin-17, Interleukin-23, Tgf-Β in Pemphigus Vulgaris Patients, and Their Association With Disease Phase. Dermatologic Therapy. 2020;33(6):-. |
BibTex | @article{ author = {Gholibeigian Z and Izad M and Daneshpazhooh M and Mortazavi H and Salehi Z and Behruzifar S and Akhdar M and Tavakolpour S and Azizpour A}, title = {Decreased Serum Levels of Interleukin-17, Interleukin-23, Tgf-Β in Pemphigus Vulgaris Patients, and Their Association With Disease Phase}, journal = {Dermatologic Therapy}, volume = {33}, number = {6}, pages = {-}, year = {2020} } |
RIS | TY - JOUR AU - Gholibeigian Z AU - Izad M AU - Daneshpazhooh M AU - Mortazavi H AU - Salehi Z AU - Behruzifar S AU - Akhdar M AU - Tavakolpour S AU - Azizpour A TI - Decreased Serum Levels of Interleukin-17, Interleukin-23, Tgf-Β in Pemphigus Vulgaris Patients, and Their Association With Disease Phase JO - Dermatologic Therapy VL - 33 IS - 6 SP - EP - PY - 2020 ER - |